Bioage Labs (BIOA) traded down -7.78 % during a 24 hours period ending at 02:00 AM Central Europe on Tuesday 27th. One Bioage Labs stock can currently be bought for about USD 4.99 on popular exchanges. Current supply of Bioage Labs stocks is 45.9 mn. Bioage Labs has a current market capitalization of USD 234.1 mn and approximately USD 2.4 mn worth of Bioage Labs was traded on exchanges in the last 24 hours. Since last month end, Bioage Labs has traded -29.26 % down. Simple moving average of last 200 days is at USD 16.12. The highest price of past 52 weeks was recorded at USD 25.96 on 07/06/2026. 52 weeks low was at USD 4.81 on 10/16/2026.
Here is how related stocks have performed in the past 24 hours:
Fulcrum Therapeutics (FULC) traded flat 0 % and now trades at USD 3.64. Fulcrum Therapeutics has a market capitalisation of USD 280.8 mn.
Clearpoint Neuro (CLPT) traded down -1.19 % and now trades at USD 9.04. Clearpoint Neuro has a market capitalisation of USD 278.8 mn.
Arcturus Therapeutics Holdin (ARCT) traded down -8.29 % and now trades at USD 9.91. Arcturus Therapeutics Holdin has a market capitalisation of USD 279.7 mn.
Infusystem (INFU) traded down -1.41 % and now trades at USD 13.81. Current market capitalisation for Infusystem is USD 277.7 mn. Current price/earnings ratio for Infusystem is 34.53.
Treace Medical Concepts (TMCI) traded down -0.23 % and now trades at USD 4.42. Treace Medical Concepts has a market capitalisation of USD 277.7 mn.